Assessment of Procedural Outcomes in Mitral TEER: Challenges and Unmet Needs
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; GE Healthcare; Medtronic; Valgen; Neochord; Half Moon Medical; Shifamed; Abbott; Nyra; Meacor; Philips; Biosense Webster; Arcos
- Equity/Stock(s)/Options - Tioga; Arcos; Meacor